Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
about
Relationship between funding source and conclusion among nutrition-related scientific articlesA comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persistsReporting bias in medical research - a narrative reviewA systematic review with procedural assessments and meta-analysis of low level laser therapy in lateral elbow tendinopathy (tennis elbow)Effectiveness of second generation antipsychotics: a systematic review of randomized trialsFactors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than othersIndustry sponsorship and research outcomeSuperficial heat or cold for low back painBicyclol for chronic hepatitis COutcome reporting among drug trials registered in ClinicalTrials.govAssociation between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addictionCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsConflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journalsFunding source, trial outcome and reporting quality: are they related? Results of a pilot studyHow does PLoS medicine manage competing interests?What is the influence of randomisation sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological studyImplementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigationDo randomized controlled trials discuss healthcare costs?Factors associated with results and conclusions of trials of thiazolidinedionesPatient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian surveyEthics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public healthSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsConflict of interest policies for organizations producing a large number of clinical practice guidelinesPrevalence of industry support and its relationship to research integrityThe fading of reported effectiveness. A meta-analysis of randomised controlled trials.Dacron vs. PTFE as bypass materials in peripheral vascular surgery--systematic review and meta-analysis.Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.Characteristics associated with citation rate of the medical literature.Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic reviewThe impact of National Institutes of Health funding on U.S. cardiovascular disease research.Variability in conflict of interest disclosures by physicians presenting trauma research.Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial.Interpreting systematic reviews: are we ready to make our own conclusions? A cross-sectional study.A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis.The contract research organization and the commercialization of scientific research.Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.Identifying items to assess methodological quality in physical therapy trials: a factor analysisReporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.
P2860
Q21092377-97794DFD-64FF-499D-B8F5-AE4C27BBFE17Q21144620-A69E6509-92E3-4AC5-9546-FD17840C7494Q21203744-B6B5A860-6D59-4722-B0C0-1DC1F460F9B2Q21257145-37AB86E4-1045-4E75-AA2C-605A66C99C52Q21260262-E0AC1086-9417-44F4-A5B2-ABCFBA2340AFQ21563421-88D39535-951B-4876-A30A-D6FC8F746AC8Q24202591-C0DF9561-3EB3-4C3A-BAA7-D399662EB995Q24244844-2F462471-AB5F-4EB7-93DD-3CF226A3F179Q24246509-28E9D227-D165-418A-8B9F-34ECE6E4C516Q24289273-270AFC24-1889-4CFA-9383-C06286FB1079Q24596233-AE5F6E4D-90DB-4556-845F-5DECDF717463Q24601455-CEAA7663-E315-4CE1-B7FF-950C52E9566DQ24614627-8DD51341-6BAB-4E18-8C3E-42AAE5A2840FQ24644642-5D378230-E8D7-489C-918C-50F9A1589EEDQ24802299-C3470252-076B-411C-AC8D-0A97839B1F93Q24805628-1C12E80D-FA1D-40D3-AA42-F01C4B1C7038Q26785604-863E2400-331F-46DB-A26D-3FBCDD7E4465Q27498844-335AA71C-9714-48CC-9231-CB31AE52009AQ28475247-EAFE2B58-8455-4467-99C8-1BE511FCD3C0Q28475588-FD22A7B9-2366-450E-B955-DF85AD104BC2Q28483619-B9A5A02B-DEEF-4D7E-AEF8-14FA88584B56Q28645777-DBAF1F37-33C7-4DAD-BB63-2231706B99A5Q28710019-CE7B2B3A-1857-4FE6-95E6-A45413C9A868Q28729747-DE31993F-88C3-4613-ACA4-B34323795BF8Q30438220-0933EDC2-5AA7-4CEA-835B-7881ED201802Q30814884-7300178B-EB36-480E-AB64-6700E1B82AF5Q30855701-82FA1438-79A8-403D-BBC6-45BFC05D3410Q31161134-3CA71FBD-55A7-4289-8553-AE7C8411ECA3Q33211922-FF01F85D-D30F-472E-8CDA-B4ABC793034CQ33283512-4C26B97E-D5C9-4E3D-9292-7C4697950FF4Q33408691-BF712E1A-0974-4BE5-866C-350E68FCA1BEQ33488538-C96C5574-1259-4524-BCF7-38BB4C9434CDQ33577335-10F32E27-2C4E-41CD-A06B-74D0B3FCBA34Q33617087-DC3A9554-8D28-4E4B-953B-6F5659170F8DQ33857706-92F67BDF-C5EE-405E-9465-CC41C64E635BQ33928843-4AD4FF0E-7409-4763-ABFB-71EDF0008193Q33991605-C757D03D-F9B5-4566-AB3C-7BBC1DC6534DQ34025773-6DF9864C-13A3-4325-96FE-E5BFA8F14FABQ34135659-05C172F7-B153-488F-BA5D-E80DDE098D31Q34294990-1B121E2E-C758-4149-ACC3-26ED007AF562
P2860
Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Association between competing ...... al trials published in the BMJ
@ast
Association between competing ...... al trials published in the BMJ
@en
type
label
Association between competing ...... al trials published in the BMJ
@ast
Association between competing ...... al trials published in the BMJ
@en
prefLabel
Association between competing ...... al trials published in the BMJ
@ast
Association between competing ...... al trials published in the BMJ
@en
P2860
P356
P1433
P1476
Association between competing ...... al trials published in the BMJ
@en
P2093
Bodil Als-Nielsen
Lise L Kjaergard
P2860
P356
10.1136/BMJ.325.7358.249
P407
P577
2002-08-01T00:00:00Z